Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results.

Dignass A, Akbar A, Hart A, Subramanian S, Bommelaer G, Baumgart DC, Grimaud JC, Cadiot G, Makins R, Hoque S, Bouguen G, Bonaz B

Open source

DOI
10.1093/ecco-jcc/jjw032
Published
2016 Jul
Container
Journal of Crohn's & colitis
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ecco-jcc/jjw032,
  title = {Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results.},
  author = {Dignass A and Akbar A and Hart A and Subramanian S and Bommelaer G and Baumgart DC and Grimaud JC and Cadiot G and Makins R and Hoque S and Bouguen G and Bonaz B},
  year = {2016},
  journal = {Journal of Crohn's \& colitis},
  doi = {10.1093/ecco-jcc/jjw032},
  url = {https://doi.org/10.1093/ecco-jcc/jjw032}
}

RIS

TY  - JOUR
TI  - Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results.
AU  - Dignass A
AU  - Akbar A
AU  - Hart A
AU  - Subramanian S
AU  - Bommelaer G
AU  - Baumgart DC
AU  - Grimaud JC
AU  - Cadiot G
AU  - Makins R
AU  - Hoque S
AU  - Bouguen G
AU  - Bonaz B
PY  - 2016
JO  - Journal of Crohn's & colitis
DO  - 10.1093/ecco-jcc/jjw032
UR  - https://doi.org/10.1093/ecco-jcc/jjw032
ER  - 

APA

A, D., A, A., A, H., S, S., G, B., DC, B., JC, G., G, C., R, M., S, H., G, B., & B, B. (2016). Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results.. Journal of Crohn's & colitis. https://doi.org/10.1093/ecco-jcc/jjw032

Source records